Global Erectile Dysfunction Drugs Market 2019-2023| Presence of Novel Drug Formulations in the Late Stages of Development to Boost Growth| Technavio
LONDON--(BUSINESS WIRE)--Apr 17, 2019--The global erectile dysfunction (ED) drugs market is expected to post a CAGR of over (4)% during the period 2019-2023. The market is expected to decelerate on a year-on-year basis during the forecast period.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190417005622/en/
The global erectile dysfunction (ED) drugs market will post a CAGR of over (4)% during the period 2019-2023 (Graphic: Business Wire)
With the increasing health consciousness across the globe, there has been a significant increase in healthcare spending for sexual wellness. The physical and hormonal changes in the body associated with aging, lead to a decrease in libido, a side-effect of ED. Hence, ED is more common among the geriatric population, and there has been a rise in the demand for ED drugs among this population. Moreover, the therapeutic benefits of these drugs, such as longer half-life in the body and the ease of administration even via the sublingual route, are expected to drive the adoption of ED drugs. The rising cyberpornography and the increasing number of advertisements for the treatment of ED are also expected to drive the growth of the market during the forecast period.
As per Technavio, the presence of novel drug formulations in the late stages of development will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global erectile dysfunction drugs market research report also analyzes other important trends and market drivers that will affect market growth during 2019-2023.
Global erectile dysfunction drugs market: Presence of novel drug formulations in the late stages of development
Currently, the market is dominated by the oral formulations of the drugs used for the treatment of ED. However, during the forecast period, several novel formulations of ED drugs, such as topical gels, injectables, and suppositories, are expected to emerge in the market. These novel formulations will attract a large number of patients, owing to their therapeutic benefits. They are also expected to widen the scope of treatment for ED.
“Apart from the presence of novel drug formulations in the late stages of development, the rising awareness of ED is increasing across the globe as it is an underdiagnosed and undertreated disorder. To overcome the lack of awareness regarding the conditions that lead to ED, several organizations, healthcare agencies, and government bodies are also focusing on improving the quality of life of the patients, which will boost the growth of the global erectile dysfunction drugs market,” says a senior analyst at Technavio.
Global erectile dysfunction drugs market: Segmentation analysis
This market research report segments the global erectile dysfunction drugs market by product (topical drugs and oral drugs) and geographical regions (North America, Europe, Asia, and ROW).
The North American region led the market in 2018, followed by Europe, Asia, and ROW, respectively. However, this region will exhibit a slow growth rate as compared to the rest of the regions in the forecast period.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market size and forecast
Five Forces Analysis
- Regional comparison
- Key leading countries
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at email@example.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190417005622/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: SENIORS HEALTH ALTERNATIVE MEDICINE FITNESS & NUTRITION PHARMACEUTICAL OTHER HEALTH COMMUNICATIONS MARKETING OTHER SCIENCE CONSUMER SCIENCE GENERAL HEALTH MEN
SOURCE: Technavio Research
Copyright Business Wire 2019.
PUB: 04/17/2019 11:31 AM/DISC: 04/17/2019 11:31 AM